Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SENSEI BIOTHERAPEUTICS, INC.

(SNSE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
10.34(c) 11.23(c) 11.6(c) 11.31(c) 11.49(c) Last
143 159 160 723 71 097 61 467 91 099 Volume
+6.38% +8.61% +3.29% -2.50% +1.59% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -33,4 M - -
Net cash position 2021 143 M - -
P/E ratio 2021 -9,93x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -42,8 M - -
Net cash position 2022 104 M - -
P/E ratio 2022 -8,45x
Yield 2022 -
Capitalization 351 M 351 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 31
Free-Float 63,4%
More Financials
Company
Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in the discovery and development of therapies with focus on treatments for cancer. Its ImmunoPhage platform is a self-adjuvanted and differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response. The Company is engineering its... 
More about the company
Ratings of Sensei Biotherapeutics, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
C-
More Ratings
All news about SENSEI BIOTHERAPEUTICS, INC.
09/08SENSEI BIOTHERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
08/11SENSEI BIOTHERAPEUTICS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/04SENSEI BIOTHERAPEUTICS : Reports Second Quarter 2021 Results and Highlights (Form 8-K)
PU
08/04SENSEI BIOTHERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial St..
AQ
08/04Sensei Biotherapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June..
CI
08/04Sensei Biotherapeutics Reports Second Quarter 2021 Results and Highlights Recent In Viv..
GL
08/02SENSEI BIOTHERAPEUTICS : Departure of Directors or Certain Officers; Election of Directors..
PU
08/02SENSEI BIOTHERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/02Sensei Biotherapeutics, Inc. Appoints Kristian Humer as Director and as Member of the i..
CI
08/02SENSEI BIOTHERAPEUTICS : Appoints Kristian Humer to its Board of Directors
AQ
08/02Certain Warrants of Sensei Biotherapeutics, Inc. are subject to a Lock-Up Agreement End..
CI
08/02Certain Stock Options of Sensei Biotherapeutics, Inc. are subject to a Lock-Up Agreemen..
CI
08/02Certain Common Stock of Sensei Biotherapeutics, Inc. are subject to a Lock-Up Agreement..
CI
07/06SENSEI BIOTHERAPEUTICS : Piper Sandler Adjusts Price Target on Sensei Biotherapeutics to $..
MT
07/01SENSEI BIOTHERAPEUTICS : Berenberg Downgrades Sensei Biotherapeutics to Hold from Buy, Set..
MT
More news
News in other languages on SENSEI BIOTHERAPEUTICS, INC.
06/11Magic-Mushroom-Biotech Atai strebt bei IPO Bewertung von 2,3 Mrd Dollar an
More news
Analyst Recommendations on SENSEI BIOTHERAPEUTICS, INC.
More recommendations
Chart SENSEI BIOTHERAPEUTICS, INC.
Duration : Period :
Sensei Biotherapeutics, Inc. Technical Analysis Chart | SNSE | US81728A1088 | MarketScreener
Technical analysis trends SENSEI BIOTHERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 11,49 $
Average target price 12,00 $
Spread / Average Target 4,44%
EPS Revisions
Managers and Directors
John K. Celebi President, Chief Executive Officer & Director
Erin Colgan Senior Vice President-Finance & Administration
Marie-Louise Fjaellskog Chief Medical Officer
Robert H. Pierce Chief Scientific Officer
Alice Drumheller Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
SENSEI BIOTHERAPEUTICS, INC.0.00%351
GILEAD SCIENCES, INC.22.19%89 259
BIONTECH SE309.08%80 542
WUXI APPTEC CO., LTD.34.39%68 685
REGENERON PHARMACEUTICALS32.25%66 425
VERTEX PHARMACEUTICALS-22.31%47 634